UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000027581
Receipt No. R000031510
Scientific Title Safety and efficacy of neoadjuvant hormone therapy with combination of Estramustine Phosphate Sodium Hydrate and LH-RH agonist for high-risk prostate cancer treated with intensity modulated radiotherapy
Date of disclosure of the study information 2017/05/31
Last modified on 2020/01/06 10:42:33

No. Disposal Last modified on Item of update
1 Insert 2017/05/31 21:58:56
2 Update 2017/12/01 08:40:02 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Results
Results
3 Update 2020/01/06 10:37:30 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
4 Update 2020/01/06 10:40:47 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
5 Update 2020/01/06 10:42:33 Date of IRB


Contact us.